Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)
China · Delayed Price · Currency is CNY 5.75
-0.15 (-2.54%)
Sep 10, 2026, 12:14 PM CST
Beijing SL Pharmaceutical Revenue
Beijing SL Pharmaceutical had revenue of 114.64M CNY in the quarter ending June 30, 2026, a decrease of -15.68%. This brings the company's revenue in the last twelve months to 570.26M, down -0.51% year-over-year. In the year 2025, Beijing SL Pharmaceutical had annual revenue of 623.64M, down -5.57%.
Revenue (ttm)
570.26M
Revenue Growth
-0.51%
P/S Ratio
10.63
Revenue / Employee
632.92K
Employees
901
Market Cap
6.06B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 623.64M | -36.78M | -5.57% |
| Dec 31, 2024 | 660.42M | -357.94M | -35.15% |
| Dec 31, 2023 | 1.02B | -31.81M | -3.03% |
| Jan 1, 2023 | 1.05B | -164.65M | -13.55% |
| Jan 1, 2022 | 1.21B | 102.08M | 9.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.